The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats
Open accessAbstract
Infusion of mesenchymal stem cells (MSCs) has been shown to effectively lower blood glucose in diabetic individuals, but the mechanism involved could not be adequately explained by their potential role in promoting islet regeneration. We therefore hypothesized that infused MSCs might also contribute to amelioration of the insulin resistance of peripheral insulin target tissues. To test the hypothesis, we induced a diabetic rat model by high-fat diet/streptozotocin (STZ) administration, performed MSC infusion during the early phase (7 days) or late phase (21 days) after STZ injection, and then evaluated the therapeutic effects of MSC infusion and explored the possible mechanisms involved. MSC infusion ameliorated hyperglycemia in rats with type 2 diabetes (T2D). Infusion of MSCs during the early phase not only promoted β-cell function but also ameliorated insulin resistance, whereas infusion in the late phase merely ameliorated insulin resistance. Infusion of MSCs resulted in an increase of GLUT4 expression and an elevation of phosphorylated insulin receptor substrate 1 (IRS-1) and Akt (protein kinase B) in insulin target tissues. This is the first report of MSC treatment improving insulin sensitivity in T2D. These data indicate that multiple roles and mechanisms are involved in the efficacy of MSCs in ameliorating hyperglycemia in T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Phinney, D. G., & Prockop, D. J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0637 · Cited by 1,908
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445
Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood
Bieback, K., Kern, S., Klüter, H., & Eichler, H. (2004) · Stem Cells · doi:10.1634/stemcells.22-4-625 · Cited by 931
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
Gual, P., Le Marchand-Brustel, Y., & Tanti, J.-F. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.019 · Cited by 912 · cited 1×
“The inability of feeding to induce the elevation of phosphorylated IRS-1 and Akt is currently believed to be a hallmark of insulin insensitivity or resistance in T2D animal models (33).”
BackgroundA new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M., & Reaven, G. M. (2000) · Metabolism · doi:10.1053/meta.2000.17721 · Cited by 848
Ianus, A., Holz, G. G., Theise, N. D., & Hussain, M. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16502 · Cited by 772
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743
Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608249103 · Cited by 710
Bone marrow–derived stem cells initiate pancreatic regeneration
Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D. A., & Bhatia, M. (2003) · Nature Biotechnology · doi:10.1038/nbt841 · Cited by 614
Mesenchymal stem cell therapy: Two steps forward, one step back
Ankrum, J., & Karp, J. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.02.005 · Cited by 614
Immunomodulation by Mesenchymal Stem Cells
Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M., & Sayegh, M. H. (2008) · Diabetes · doi:10.2337/db08-0180 · Cited by 463
Fraulob, J. C., Ogg-Diamantino, R., Fernandes-Santos, C., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-83 · Cited by 448
Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E., & Kitabchi, A. E. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.010 · Cited by 343
Ezquer, F. E., Ezquer, M. E., Parrau, D. B., Carpio, D., Yañez, A. J., & Conget, P. A. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.01.006 · Cited by 343
Chao, K. C., Chao, K. F., Fu, Y. S., & Liu, S. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001451 · Cited by 340
Park, K.-S., Kim, Y.-S., Kim, J.-H., Choi, B., Kim, S.-H., Tan, A. H.-K., Lee, M.-S., Lee, M.-K., Kwon, C.-H., Joh, J.-W., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181c7dc99 · Cited by 288
MSCs: Biological characteristics, clinical applications and their outstanding concerns
Si, Y.-L., Zhao, Y.-L., Hao, H.-J., Fu, X.-B., & Han, W.-D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.005 · Cited by 259
Self-citationGLUT2 mutations, translocation, and receptor function in diet sugar managing
Leturque, A., Brot-Laroche, E., & Le Gall, M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2009 · Cited by 245
Hirshman, M. F., Goodyear, L. J., Wardzala, L. J., Horton, E. D., & Horton, E. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40147-6 · Cited by 243
Mesenchymal stromal cells: tissue repair and immune modulation
Le Blanc, K. (2006) · Cytotherapy · doi:10.1080/14653240601045399 · Cited by 220
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study
Jiang, R., Han, Z., Zhuo, G., Qu, X., Li, X., Wang, X., Shao, Y., Yang, S., & Han, Z. C. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0116-z · Cited by 218
Sahin, K., Onderci, M., Tuzcu, M., Ustundag, B., Cikim, G., Ozercan, İ. H., Sriramoju, V., Juturu, V., & Komorowski, J. R. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.021 · Cited by 178
Xie, Q., Huang, H., Xu, B., Dong, X., Gao, S., Zhang, B., & Wu, Y. (2009) · Differentiation · doi:10.1016/j.diff.2009.01.001 · Cited by 152
Anzalone, R., Iacono, M. L., Loria, T., Stefano, A. D., Giannuzzi, P., Farina, F., & Rocca, G. L. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9196-4 · Cited by 151
Modification of mesenchymal stem cells for cardiac regeneration
Song, H., Song, B., Cha, M., Choi, I., & Hwang, K.-C. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903455997 · Cited by 107
Mizuno, H. (2010) · PubMed · Cited by 104
Rencurel, F., Waeber, G., Antoine, B., Rocchiccioli, F., MAULARD, P., Girard, J. R., & Leturque, A. (1996) · Biochemical Journal · doi:10.1042/bj3140903 · Cited by 104
Ho, J. H., Tseng, T.-C., Ma, W.-H., Ong, W.-K., Chen, Y.-F., Chen, M.-H., Lin, M., Hong, C.-Y., & Lee, O. K. (2011) · Cell Transplantation · doi:10.3727/096368911x603611 · Cited by 87
Stem cell transplantation for neurodegenerative diseases
Rosser, A., Zietlow, R., & Dunnett, S. B. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f132fc · Cited by 79
Bell, G. I., Broughton, H. C., Levac, K. D., Allan, D., Xenocostas, A., & Hess, D. A. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0583 · Cited by 77
Emerging treatment options for type 2 diabetes
Piya, M. K., Tahrani, A. A., & Barnett, A. H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03711.x · Cited by 76
Waller, A. P., Burns, T. A., Mudge, M. C., Belknap, J. K., & Lacombe, V. A. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0674.x · Cited by 76
Haluzík, M., Lacinová, Z., Dolinkova, M., Haluzíková, D., Housa, D., Hořínek, A., Vernerová, Z., Kumstyrova, T., & Haluzík, M. (2006) · Endocrinology · doi:10.1210/en.2005-1624 · Cited by 62
Diabetes in Mice With Selective Impairment of Insulin Action in Glut4-Expressing Tissues
Lin, H. V., Ren, H., Samuel, V. T., Lee, H., Lu, T. Y., Shulman, G. I., & Accili, D. (2011) · Diabetes · doi:10.2337/db10-1056 · Cited by 61
Napoli, R., Hirshman, M. F., & Horton, E. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118053 · Cited by 52
Coronel, M. F., Musolino, P. L., & Villar, M. J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.06.018 · Cited by 28
Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse
Shen, H.-Q., Zhu, J. S., & Baron, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90191-9 · Cited by 15
Peptide rescues GLUT4 recruitment, but not GLUT4 activation, in insulin resistance
Funaki, M., Herr, K. B., & Randhawa, P. K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.153 · Cited by 6
Cited by
Modeling type 2 diabetes in rats using high fat diet and streptozotocin
Skovsø, S. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12235 · Cited by 596
Sun, Y., Shi, H., Yin, S., Ji, C., Zhang, X., Zhang, B., Wu, P., Shi, Y., Mao, F., Yan, Y., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07643 · Cited by 460
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Hmadcha, A., Martin-Montalvo, A., Gauthier, B. R., Soria, B., & Capilla-Gonzalez, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00043 · Cited by 341
Bhansali, S., Dutta, P., Kumar, V., Yadav, M. K., Jain, A., Mudaliar, S., Bhansali, S., Sharma, R. R., Jha, V., Marwaha, N., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0275 · Cited by 126
Song, J., Liu, J., Cui, C., Hu, H., Zang, N., Yang, M., Yang, J., Zou, Y., Li, J., Wang, L., et al. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13177 · Cited by 118
Self-citation
Metadata
- Authors
- Si, Y., Zhao, Y., Hao, H., Liu, J., Guo, Y., Mu, Y., Shen, J., Cheng, Y., Fu, X., & Han, W.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-05-14
- Volume
- 61
- Issue
- 6
- Pages
- 1616-1625
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2112270957
- Cited by
- 271
- References
- 40
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.